Literature DB >> 23232305

Surgical treatment of atrial septal defect in a patient with familial antithrombin-III deficiency.

Tsutomu Hattori1, Mitsumasa Hata, Akira Sezai, Shinji Wakui, Motomi Shiono.   

Abstract

PURPOSE: A 41-year-old woman with familial antithrombin-III deficiency was admitted to our hospital for patch closure of an atrial septal defect. Antithrombin-III activity was 43% and its antigen level was 12.2 mg/dl, was diagnosed so type I antithrombin-III deficiency was diagnosed.
METHODS: A dose of 2500 U of antithrombin-III concentrate was administered at 1 day before surgery, 1 hour before surgery, and 1 day after surgery. Heparinazation was performed at 200 IU/kg and the activated clotting time increased from a baseline of 140s to 622s. After establishing cardiopulmonary bypass and cardioplegic arrest, closure of the septal defect was done with a pericardial patch.
RESULTS: The activated clotting time was maintained at more than 400s during cardiopulmonary bypass. There were no intraoperative complications and the postoperative course was uneventful.
CONCLUSION: In patients with familial antithrombin-III deficiency, administration of antithrombin-III concentrate is effective when cardiopulmonary bypass is required.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232305     DOI: 10.5761/atcs.cr.12.01981

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  1 in total

1.  Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency.

Authors:  Yoshiyuki Nishimura; Yasushi Takagi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-04-20       Impact factor: 1.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.